Authorized purpose: LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.
Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Authorized purpose: LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.
Overview status: Source-reviewed overview
What does this software do?Authorized purpose: LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Chest/Lung Input: One or more 2D MRI time series for lung analysis.
Who uses it?Intended users: Healthcare professionals.
What does the software produce?Output: Lung ventilation/perfusion maps and statistical evaluation.
What is its most important limitation?Key limitation: Results when interpreted by a radiologist may assist in diagnosis; the results shall not be used as the only source for diagnosis.
Clinical takeaway
Clinical role: LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.
Evidence takeaway
Evidence from the reviewed source record: Non-clinical testing used 342 test images; the average Dice score was 0.91, the average Hausdorff distance was 4.1 pixels (SD = 3.9), the average surface distance was 0.8 pixels (SD = 0.8), the average absolute volumetric difference was 2.5 (SD = 159.5), and the relative volumetric difference was 3.2 (SD = 21.4). The representative dataset included 0.55T, 1.5T, and 3T MRI systems and subjects aged 6 to 85 years; no clinical tests were conducted for the subject device.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
LungMaps processes one or more 2D lung MRI time series to support radiologist interpretation of ventilation and perfusion maps; it is not the sole source for diagnosis.
FDA source
Exact FDA submission
Checked 2026-09-19
Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Current training and support terms were not established.
Monitoring and change control
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-08-13
Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Vendor family environment
The vendor describes lung map and parameter-report workflows with syngo MR and syngo.via requirements.
product family ยท checked 2026-09-05
That page states the offering is under development and not commercially available; it does not negate FDA clearance or establish U.S. commercial availability.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
Non-clinical testing used 342 test images; the average Dice score was 0.91, the average Hausdorff distance was 4.1 pixels (SD = 3.9), the average surface distance was 0.8 pixels (SD = 0.8), the average absolute volumetric difference was 2.5 (SD = 159.5), and the relative volumetric difference was 3.2 (SD = 21.4). The representative dataset included 0.55T, 1.5T, and 3T MRI systems and subjects aged 6 to 85 years; no clinical tests were conducted for the subject device.
FDA source
Exact FDA submission
Checked 2026-09-19
The exact FDA summary reports the test-set size, segmentation metrics, field strengths, age range, and absence of clinical tests.
These are common procurement questions; unknown values remain visible until a source supports them.
Pricing and total cost
Vendor documentation pending
Vendor confirmation
Exact FDA submission
Checked 2026-09-06
No scoped public price or procurement award was reviewed.
Reimbursement and coding
Research pending
Needs research
Exact FDA submission
Checked 2026-09-06
No applicable payer policy was reviewed.
Safety and lifecycle
Postmarket record
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Buyer worksheet
Open questions to take to the vendor
Verify security and privacy controls: No dated, scoped security evidence was reviewed.
Verify training: Current training and support terms were not established.
Verify pricing and total cost: No scoped public price or procurement award was reviewed.
Verify reimbursement and coding relevance: No applicable payer policy was reviewed.
Verify local validation and lifecycle monitoring: Local acceptance testing, production monitoring, drift review, update control, and incident escalation require a current vendor and site-specific governance plan.
Verify recalls and postmarket safety signals: No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-19Last searched
25Fields reviewed
11Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
No stored PubMed or ClinicalTrials candidates. Native-submission recall candidate snapshot was zero. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision material, vendor product page, literature index, trial registry, fda device recall, fda decision summary packet, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history7 sources - 3 history items
Vantage Fortian and Orian 1.5T produce diagnostic MR images of the head and body, including labeled noncontrast angiography, for trained technologists and physician interpretation.
S-scan Open is an Esaote MR system for diagnostic image acquisition, reconstruction, display, and professional interpretation within the labeled scanner, coil, sequence, and...